title: Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
abstract: Combined-modality therapy for organ preservation represents an appropriate alternative to radical surgery in the management of several malignant diseases. The standard therapy for muscle-invasive bladder cancer in the United States has been radical cystectomy. Although the sequelae of radical surgery have been ameliorated somewhat by techniques for the construction of orthotopic bladders, the ideal therapy should both cure the patient of cancer and maintain a functioning natural bladder. Years of experience in Europe and Canada with bladder preservation using radiation therapy are documented. Advances in transurethral surgery technique and in the combination of radiation and chemotherapy have led to safe and effective regimens for patients with bladder cancer. Several recent trials with combined-modality therapy have established this treatment as a viable alternative to radical cystectomy in selected patients.
authors.affiliation: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
authors.forename: K T
authors.initials: KT
authors.lastname: Colvett
authors.forename: A F
authors.initials: AF
authors.lastname: Althausen
authors.forename: B
authors.initials: B
authors.lastname: Bassil
authors.forename: N M
authors.initials: NM
authors.lastname: Heney
authors.forename: F V
authors.initials: FV
authors.lastname: McGovern
authors.forename: H H
authors.initials: HH
authors.lastname: Young
authors.forename: D S
authors.initials: DS
authors.lastname: Kaufman
authors.forename: A L
authors.initials: AL
authors.lastname: Zietman
authors.forename: W U
authors.initials: WU
authors.lastname: Shipley
mesh_terms: D001918:Brachytherapy; D003131:Combined Modality Therapy; D015653:Cystectomy / Q000379:methods; D006801:Humans; D009361:Neoplasm Invasiveness; D018579:Patient Selection; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D016879:Salvage Therapy; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*